About Us

Innovation for good health

Connecting patients to the medicines they need

Created as an entrepreneurial business entity, Fosun Pharma USA Inc. is a US-focused innovative specialty pharma company driven by its internal R&D and strategic partnerships.

Led by a team of highly experienced executives with strong track records of leading US and European pharmaceutical companies, both in commercial operations and R&D, Fosun Pharma USA markets a portfolio of specialty pharmaceutical injectable products and ophthalmics and is building a portfolio of high-value branded, innovative products.

Areas of focus

We're building a portfolio of high-value branded, innovative products with a diverse pipeline that reflects therapeutic areas of focus addressing the unmet medical needs of patients.

Investment highlights

Fosun Pharma USA investment highlights

Near term, we’ve invested in our lead oncology product serplulimab with an expected launch in 2026. Serplulimab shows strong results based on our international phase 3 study ASTRUM-005 with a mOS of 15.8 months. We continue to build our portfolio through access to our parent company’s pipeline and capabilities to reduce cost and increase speed to market.

Strategic Partnerships

Strategic alliances and partnerships form a critical foundation for our continued growth and success

Fosun Pharma USA’s areas of interest cover several therapeutic areas. An area of current focus is oncology. We have a pipeline of innovative oncology products in development and significant expertise in the field. We are actively looking for late development stage or commercial stage partnerships in oncology.